Petmed Express Inc(PETS-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low1.9500
Day High1.9899
Open:1.9500
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
GlobeNewswire
PetMed Express, Inc. Confirms Receipt of Unsolicited, Non-Binding, and Conditional Acquisition Proposal from SilverCape Investments Limited
Tipranks
PetMed Express announces routine board transition and vacancy
Zacks Investment Research
PETS Q4 Earnings Call Focuses on Turnaround Foundation
PETS Q4 Earnings Call Focuses on Turnaround Foundation
Tipranks
PetMed Express Earnings Call Shows Painful Turnaround
Motley Fool
PetMed Express (PETS) Q4 2026 Earnings Transcript
GlobeNewswire
PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results
GlobeNewswire
PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026
Tipranks
PetMed Express Sets Key Deadlines for 2026 Shareholder Nominations
GlobeNewswire
PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels
Tipranks
PetMed Express Shareholders Approve Directors, Pay and Auditor
GlobeNewswire
PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited
GlobeNewswire
PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them
GlobeNewswire
PetMeds Extends Existing Shareholder Rights Plan
Tipranks
PetMed Express Faces Nasdaq Compliance Notice
Tipranks
PetMed Express Delays Quarterly Report Filing
Tipranks
Petmed Express Appoints Interim CEO and President
GlobeNewswire
PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as Director and Audit Committee Chair
GlobeNewswire
PetMeds® Files Form 10-K for Fiscal 2025
Business Wire
Securities Fraud Investigation Into PetMed Express, Inc. (PETS) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Profile

PetMed Express, Inc. and subsidiaries, d/b/a 1-800-PetMeds (the `Company`), is a leading nationwide pet pharmacy. The Company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The Company offers consumers an attractive alternative for obtaining pet medications in terms of convenience, price, and speed of delivery. The Company markets its products through national advertising campaigns, which aim to increase the recognition of the `1-800-PetMeds` brand name, and `PetMeds` family of trademarks, increase traffic on its website at www.1800petmeds.com, acquire new customers, and maximize repeat purchases. The majority of the Company's sales are to residents in the United States. The Company's corporate headquarters and distribution facility are located in Delray Beach, Florida.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.